104.87
0.27%
+0.28
Handel nachbörslich:
104.73
-0.14
-0.13%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Abbott Laboratories Aktie (ABT) Neueste Nachrichten
Abbott reports more HeartMate LVAD problems - Mass Device
Mass Device
Abbott reports more HeartMate LVAD problems - Mass Device
Mass Device
Lactulose API Market Share Key Trends By Key Players-Abbott - openPR
openPR
FDA recalls Abbott's HeartMate 3 ventricular assist device after 2 deaths - Medical Device Network
Medical Device Network
These Dividend Stocks Are an Investor's Best Friend
The Motley Fool
Abbott Laboratories stock rises Wednesday, still underperforms market - MarketWatch
MarketWatch
Massive Insider Trade At Abbott Laboratories - Abbott Laboratories (NYSE:ABT) - Benzinga
Benzinga
Abbott has another serious HeartMate 3 recall, 2 deaths related to issue - Mass Device
Mass Device
Abbott Laboratories (ABT) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
Yahoo Finance
Abbott's new stent may help patients with peripheral artery disease - STAT
STAT
Abbott Laboratories stock underperforms Tuesday when compared to competitors - MarketWatch
MarketWatch
Looking At Abbott Laboratories's Recent Unusual Options Activity - Abbott Laboratories (NYSE:ABT) - Benzinga
Benzinga
Relative Strength Alert For Abbott Laboratories - Nasdaq
Nasdaq
Abbott Laboratories stock underperforms Monday when compared to competitors despite daily gains - MarketWatch
MarketWatch
Abbott agrees to buy Alere at lower price from earlier offer - Yahoo Singapore News
Yahoo Singapore News
What the Options Market Tells Us About Abbott Laboratories - Abbott Laboratories (NYSE:ABT) - Benzinga
Benzinga
Abbott Laboratories stock underperforms Thursday when compared to competitors - MarketWatch
MarketWatch
Drugmaker Abbott India posts Q4 profit rise on higher sales - Reuters
Reuters
Amazon, Abbott Laboratories And 2 Other Stocks Insiders Are Selling - Amazon.com (NASDAQ:AMZN) - Benzinga
Benzinga
Insider Sale: Executive Vice President Lisa Earnhardt Sells 22,852 Shares of Abbott ... - Yahoo Finance UK
Yahoo Finance UK
Abbott Laboratories stock underperforms Wednesday when compared to competitors - MarketWatch
MarketWatch
Got $1,000? 3 Dividend Stocks to Buy and Hold Forever
The Motley Fool
The Zacks Analyst Blog Highlights Tesla, Johnson & Johnson, Netflix, Abbott and ConocoPhillips
Zacks Investment Research
Insider Sale: Executive Vice President Lisa Earnhardt Sells 22,852 Shares of Abbott ... - Yahoo Finance
Yahoo Finance
Abbott Laboratories stock outperforms competitors on strong trading day - MarketWatch
MarketWatch
Q1 Earnings Season Scorecard and Fresh Analyst Reports for Tesla, JNJ & Netflix
Zacks Investment Research
Going Beyond Disaster Relief To Disaster Resilience - Abbott
Abbott
Abbott Laboratories stock outperforms competitors despite losses on the day - MarketWatch
MarketWatch
Abbott Laboratories stock outperforms competitors despite losses on the day - MarketWatch
MarketWatch
Abbott Laboratories Insiders Sold US$11m Of Shares Suggesting Hesitancy - Simply Wall St
Simply Wall St
Is Trending Stock Abbott Laboratories (ABT) a Buy Now?
Zacks Investment Research
Is Trending Stock Abbott Laboratories (ABT) a Buy Now? - Yahoo Finance
Yahoo Finance
PBH vs. ABT: Which Stock Is the Better Value Option?
Zacks Investment Research
2 Beaten-Down Dividend Stocks to Buy and Hold Forever
The Motley Fool
Better Dividend Stock: AbbVie or Johnson & Johnson?
The Motley Fool
3 Dividend Stocks to Buy and Hold for the Next Decade
The Motley Fool
Is ProShares S&P 500 Dividend Aristocrats ETF (NOBL) a Strong ETF Right Now?
Zacks Investment Research
Not A Millionaire? No Problem! Here's A 10-Stock Portfolio To Retire Comfortably
Seeking Alpha
Investors Heavily Search Abbott Laboratories (ABT): Here is What You Need to Know
Zacks Investment Research
Investors Heavily Search Abbott Laboratories (ABT): Here is What You Need to Know - Yahoo Finance
Yahoo Finance
Why I Believe Abbott Is Much Better Positioned In Today's Rising Inflation Scenario
Seeking Alpha
FDA recalls Abbott heart pumps linked to deaths, injuries - Chicago Sun-Times
Chicago Sun-Times
Results: Abbott Laboratories Beat Earnings Expectations And Analysts Now Have New Forecasts - Yahoo Finance
Yahoo Finance
This portfolio health-care stock is a buy if its post-earnings pullback continues - CNBC
CNBC
Stocks Fall As Geopolitics, Economic Worries Spook Investors, Chipmakers Sell Off, Bitcoin Tumbles To $60,000: What's Driving Markets Wednesday?
Benzinga
Abbott Laboratories (ABT) Q1 2024 Earnings Call Transcript
The Motley Fool
Q1 Earnings Review
Zacks Investment Research
Abbott Labs tops Q1 expectations, raises low end of 2024 guidance range - ABC News
ABC News
Markets Try to Shake Off April Blues
Zacks Investment Research
Abbott (ABT) Q1 Earnings Beat Estimates, Margins Contract
Zacks Investment Research
Kapitalisierung:
|
Volumen (24h):